Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)
China · Delayed Price · Currency is CNY 10.26
-0.19 (-1.82%)
Jun 11, 2026, 3:00 PM CST
SHA:603811 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 193.61 | 195.12 | 200.7 | 162.9 | 161.58 | 170.8 |
Depreciation & Amortization | 94.22 | 94.22 | 95.83 | 78.12 | 62.37 | 55.04 |
Other Amortization | 0.69 | 0.69 | 1.02 | 0.67 | 0.85 | 0.79 |
Loss (Gain) From Sale of Assets | -21.06 | -21.06 | -0.29 | 0 | -0.06 | 0.45 |
Asset Writedown & Restructuring Costs | 4.77 | 4.77 | 24 | 7.47 | 2.82 | -7.27 |
Loss (Gain) From Sale of Investments | -33.1 | -33.1 | -43.39 | -58.14 | -46.68 | -30.53 |
Provision & Write-off of Bad Debts | -0.36 | -0.36 | -2.31 | 0.94 | 0.06 | 0.52 |
Other Operating Activities | 13.87 | 13.65 | 16.71 | 20.54 | 18.25 | 3.91 |
Change in Accounts Receivable | -41.04 | -41.04 | -19.24 | -30.46 | -63.82 | -33.47 |
Change in Inventory | 8.07 | 8.07 | -20.83 | -12.03 | -3.23 | -2.11 |
Change in Accounts Payable | 38.96 | 38.96 | 24.39 | 15.44 | 31.65 | -14.67 |
Change in Other Net Operating Assets | 23.82 | 23.82 | -68.88 | - | - | -1.2 |
Operating Cash Flow | 279.11 | 280.39 | 205.72 | 194.78 | 165.94 | 143.49 |
Operating Cash Flow Growth | 10.24% | 36.30% | 5.61% | 17.38% | 15.65% | -19.30% |
Capital Expenditures | -59.81 | -45.4 | -59.89 | -70.85 | -252.85 | -134.11 |
Sale of Property, Plant & Equipment | 39.89 | 38.98 | 77.1 | 0 | 0.22 | 0.42 |
Cash Acquisitions | - | - | - | - | - | -2.26 |
Divestitures | - | - | -0.03 | - | - | - |
Investment in Securities | 11.25 | 11.25 | - | 11.25 | - | 24.4 |
Other Investing Activities | - | - | 9 | - | 11.25 | 13.34 |
Investing Cash Flow | -8.67 | 4.83 | 26.18 | -59.6 | -241.38 | -101.14 |
Long-Term Debt Issued | - | 65.7 | 177.8 | 295.2 | 562.13 | 92.46 |
Total Debt Issued | 92 | 65.7 | 177.8 | 295.2 | 562.13 | 92.46 |
Short-Term Debt Repaid | - | - | - | - | - | -1.48 |
Long-Term Debt Repaid | - | -258.58 | -389.83 | -278.73 | -286.1 | -61.38 |
Total Debt Repaid | -230.58 | -258.58 | -389.83 | -278.73 | -286.1 | -62.86 |
Net Debt Issued (Repaid) | -138.57 | -192.88 | -212.02 | 16.47 | 276.03 | 29.6 |
Issuance of Common Stock | 48.29 | 48.29 | - | - | - | - |
Repurchase of Common Stock | -9.13 | -9.13 | -67.26 | - | - | - |
Common Dividends Paid | -82.36 | -83.48 | -76.7 | -73.95 | -68.78 | -62.87 |
Other Financing Activities | 7.88 | - | - | 2.1 | - | 0.59 |
Financing Cash Flow | -173.91 | -237.21 | -355.98 | -55.38 | 207.25 | -32.67 |
Foreign Exchange Rate Adjustments | -0.23 | -0.35 | 0.29 | 0.03 | 0.2 | -0.54 |
Net Cash Flow | 96.3 | 47.67 | -123.8 | 79.83 | 132.01 | 9.14 |
Free Cash Flow | 219.3 | 234.99 | 145.83 | 123.93 | -86.92 | 9.38 |
Free Cash Flow Growth | 1.55% | 61.14% | 17.67% | - | - | -72.52% |
Free Cash Flow Margin | 26.49% | 28.93% | 20.41% | 18.45% | -13.27% | 1.35% |
Free Cash Flow Per Share | 0.69 | 0.73 | 0.44 | 0.38 | -0.26 | 0.03 |
Cash Interest Paid | - | - | - | - | - | 0.06 |
Cash Income Tax Paid | 105.59 | 103.23 | 84.61 | 35.37 | 63.86 | 96.13 |
Levered Free Cash Flow | 232.23 | 259.2 | 94.17 | 122.69 | -134.99 | -6.24 |
Unlevered Free Cash Flow | 233.93 | 261.59 | 101.1 | 132.23 | -129.28 | -3.41 |
Change in Working Capital | 26.47 | 26.47 | -86.55 | -17.72 | -33.26 | -50.22 |